Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
J Trauma ; 68(3): 571-5, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20065879

RESUMEN

BACKGROUND: : Chronic subdural hematoma (CSDH) is a relatively frequent problem in neurologic or neurosurgical practice. Although CSDH is a well-known disease, data on bilateral CSDH are scarce compared with data on unilateral CSDH. The purpose of this study was to compare the clinical presentations, precipitating factors, computed tomography (CT) scan findings, postoperative complications, and outcomes between patients with bilateral and unilateral CSDH. METHODS: : A retrospective study was performed on 129 surgical patients with CSDH from January 2002 to January 2005. These patients were divided into two groups: bilateral CSDH (45 cases) and unilateral CSDH (84 cases). Clinical presentations, precipitating factors, CT scan findings, postoperative complications, and outcomes of patients were analyzed. RESULTS: : The mean age was 75 years for patients with bilateral CSDH and was 68 years for patients with unilateral CSDH (p = 0.696). Males predominated in each group (p = 0.696). The frequency of presenting symptoms of nausea and vomiting, headache, or unsteady gait was significantly greater in bilateral CSDH than in unilateral CSDH (p < 0.05). The incidence of usage of anticoagulant and antiplatelet therapy was significantly higher in bilateral CSDH group than in unilateral CSDH group (p < 0.05). The frequency of marked midline shift on CT scans was significantly greater in unilateral CSDH than in bilateral CSDH (p < 0.05). Coexisting systemic diseases, postoperative complications, and outcomes had no significant differences between both groups. CONCLUSIONS: : Bilateral CSDH tended to occur more in patients with anticoagulant or antiplatelet therapy. Compared with patients with unilateral CSDH, patients with bilateral CSDH had more symptoms of increased intracranial pressure and lower incidences of midline shift on CT scans. Most patients with either bilateral or unilateral CSDH had a good postoperative outcome.


Asunto(s)
Hematoma Subdural Crónico/epidemiología , Hematoma Subdural Crónico/patología , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Craneotomía , Drenaje , Femenino , Hematoma Subdural Crónico/cirugía , Humanos , Masculino , Persona de Mediana Edad , Factores Desencadenantes , Estudios Retrospectivos , Factores Sexuales , Tomografía Computarizada por Rayos X , Resultado del Tratamiento , Adulto Joven
2.
Surg Neurol ; 70 Suppl 1: S1:4-8; discussion S1:8, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18617237

RESUMEN

BACKGROUND: Thyroid hormone plays a major role in normal mammalian brain maturation and affects the development of astrocytes. The expression of TR isoforms has been studied in different neoplasias. Increasing evidence has suggested that aberrant expression of TR isoforms could be associated with tumorigenesis. However, little was studied about the expression of TR isoforms in human astrocytomas. METHODS: In this study, RT-PCR was used to examine the expression of human TR isoforms in 34 human astrocytoma samples. RESULTS: We compared the TR expression between low grade (WHO grade II) and high grade (WHO grade III and IV). The frequency of TRalpha1 or TRalpha2 expression significantly decreased with the grade of malignancy (P=.005 and P=.043, respectively). However, the frequency of TRbeta1 expression significantly increased with the grades of malignancy astrocytomas (P=.017). CONCLUSIONS: Our study demonstrated for the first time that TR isoforms are indeed expressed in human astrocytomas. The expression of TR isoforms is correlated to the malignancy grading of astrocytomas. Our result provides insight into the potential use of hormonal therapy for brain tumors that overexpress or underexpress TRs.


Asunto(s)
Astrocitoma/metabolismo , Neoplasias Encefálicas/metabolismo , Receptores de Hormona Tiroidea/biosíntesis , Adolescente , Adulto , Anciano , Envejecimiento/metabolismo , Astrocitoma/patología , Neoplasias Encefálicas/patología , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , ARN/biosíntesis , ARN/genética , Receptores de Hormona Tiroidea/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Caracteres Sexuales , Receptores alfa de Hormona Tiroidea/biosíntesis , Receptores alfa de Hormona Tiroidea/genética , Receptores beta de Hormona Tiroidea/biosíntesis , Receptores beta de Hormona Tiroidea/genética
3.
Kaohsiung J Med Sci ; 24(5): 262-9, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-18508424

RESUMEN

A rare case of low-grade astrocytoma associated with abscess formation occurred in a 52-year-old man presenting with Broca's aphasia. He underwent craniotomy and tumor removal under the impression of brain tumor with necrotic cystic change. Abscess accumulation within the intra-axial tumor was found intraoperatively. Literature related to brain abscess with brain tumor is reviewed, with an emphasis on abscesses with astrocytoma. We discuss the common brain tumors that are associated with abscess, pathogens that coexist with brain tumor, and the pathogeneses of coexisting brain abscess and tumor. It is very important to know how to differentiate between and diagnose a brain abscess and tumor, or brain abscess with tumor, preoperatively from clinical presentation and through the use of computed tomography, conventional magnetic resonance imaging, diffusion-weighted imaging or magnetic resonance spectroscopy.


Asunto(s)
Astrocitoma/complicaciones , Absceso Encefálico/etiología , Neoplasias Encefálicas/complicaciones , Astrocitoma/diagnóstico , Astrocitoma/cirugía , Barrera Hematoencefálica , Absceso Encefálico/diagnóstico , Neoplasias Encefálicas/diagnóstico , Neoplasias Encefálicas/cirugía , Humanos , Imagen por Resonancia Magnética , Espectroscopía de Resonancia Magnética , Masculino , Persona de Mediana Edad
4.
J Clin Neurosci ; 12(3): 246-8, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15851074

RESUMEN

Nine patients, 16 years of age or younger with primary spinal cord tumors, diagnosed between 1991 and 2003 at The Kaohsiung University Hospital, were reviewed retrospectively. There were 2 female and 7 male patients. Two tumors were located primarily in the cervical cord (1 meningioma, 1 neurofibroma), five were predominantly thoracic (1 lymphoma, 1 meningioma, 1 astrocytoma, 1 fibrosarcoma and 1 osteoblastoma), one lumbar (ependymoma), and one sacral (Ewing's sarcoma). The most common clinical presentation was limb weakness (100%) followed by back pain (44.4%). All the patients underwent laminectomy for removal of their tumors. Five children with benign tumors improved postoperatively. At discharge, these 5 children could walk without assistance and have remained stable with long-term of follow-up. Radical surgery should be considered in benign primary spinal cord tumors. As would be expected, patients diagnosed and treated early and in whom a total resection was achieved had a better prognosis.


Asunto(s)
Neoplasias de la Columna Vertebral/patología , Neoplasias de la Columna Vertebral/terapia , Adolescente , Dolor de Espalda/etiología , Niño , Preescolar , Terapia Combinada , Femenino , Estudios de Seguimiento , Humanos , Laminectomía , Masculino , Debilidad Muscular/etiología , Recurrencia Local de Neoplasia/epidemiología , Procedimientos Neuroquirúrgicos , Estudios Retrospectivos , Neoplasias de la Columna Vertebral/cirugía , Resultado del Tratamiento
5.
J Neurosurg Spine ; 1(2): 160-7, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15347001

RESUMEN

OBJECT: Cage-assisted anterior cervical discectomy and fusion (ACDF) has proven to be a safe and effective procedure for the treatment of one- and two-level degenerative disc disease (DDD). To the authors' knowledge, clinical results after three- and four-level interbody cage-augmented ACDF have not been reported in the literature. The authors investigated the safety and effectiveness of titanium cages used in such procedures and evaluated the results in cases with or without plate fixation. METHODS: Fifty-six patients suffering from cervical DDD were divided into two groups. Group 1 included 32 patients who underwent titanium cage-assisted ACDF; Group 2 included 24 patients who underwent the same procedure, supplemented with plate fixation. The cervical DDD was confirmed by radiography and magnetic resonance imaging. The patients underwent radiographic evaluation to assess cervical lordosis, segmental height of cervical spine, the height of the foramina, and spinal stability. Neurological outcomes were assessed using the Japanese Orthopaedic Association (JOA) scores. Neck pain was graded using a 10-point visual analog scale (VAS). The follow-up period ranged from 13 to 28 months (mean 17.2 months). In both Groups 1 and 2 significant increase (p < 0.001) was demonstrated in the JOA scores (preoperatively 10.7 +/- 2.4 and 11.1 +/- 2, postoperatively 13.9 +/- 2.2 and 14.1 +/- 2.3, respectively) and VAS pain scores (preoperatively 8.8 +/- 0.9 and 8.5 +/- 1, postoperatively 3.1 +/- 2.1 and 2.8 +/- 1.8, respectively); however, there was no significant intergroup difference. A significant increase in the cervical lordosis, foraminal height, and segmental height was observed in both groups. Good stability of cage fusion was obtained in both groups 12 months postoperatively (90.6% in Group 1 and 91.7% in Group 2); however, there were no statistically significant intergroup differences. The complication rate in Group 2 was higher than that in Group 1. The hospital length of stay in Group 1 was significantly lower than in Group 2 (p < 0.001). CONCLUSIONS: Analysis of these findings demonstrated that titanium cage-assisted ACDF provided long-term stabilization, increased lordosis, increased segmental height, and increased foraminal height. In both groups good neurological outcomes were achieved and donor site morbidity was avoided. The lower complication rate and shorter hospital stay, however, make the cage-assisted fusion without plate fixation better than with plate fixation.


Asunto(s)
Placas Óseas , Vértebras Cervicales/cirugía , Discectomía/métodos , Fusión Vertebral/instrumentación , Titanio , Adulto , Anciano , Anciano de 80 o más Años , Vértebras Cervicales/diagnóstico por imagen , Femenino , Estudios de Seguimiento , Humanos , Disco Intervertebral/diagnóstico por imagen , Tiempo de Internación , Lordosis/diagnóstico por imagen , Lordosis/cirugía , Masculino , Persona de Mediana Edad , Dolor de Cuello/cirugía , Dispositivos de Fijación Ortopédica , Dimensión del Dolor , Radiografía , Rango del Movimiento Articular/fisiología , Enfermedades de la Columna Vertebral/diagnóstico por imagen , Enfermedades de la Columna Vertebral/cirugía , Resultado del Tratamiento
6.
Kaohsiung J Med Sci ; 20(9): 437-42, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15506556

RESUMEN

Magnetic resonance imaging (MRI) and proton magnetic resonance spectroscopy (MRS) were evaluated for differentiating metastatic brain tumors, radiation necroses, and brain abscesses. Twelve histologically verified lesions in 12 patients were studied using preoperative MRI and proton MRS. The signal intensities of four major metabolites, N-acetyl aspartate (NAA), choline-containing compounds (Cho), creatine and phosphocreatine (Cr), and lactate (Lac), were observed over the region of interest. Metastatic brain tumors showed a decrease in NAA/Cr and an increase in Cho/Cr ratios. Radiation necroses showed a decrease in NAA/Cr and no change in Cho/Cr ratios. Brain abscesses showed an increase in Lac/Cr ratio. Correlation with histopathologic findings showed that a high Cho signal was suggestive of a metastatic brain tumor. Lac signals were observed in brain abscesses, presumably reflecting the anerobic glycolysis of living cells. Although more cases and studies are necessary, metabolic information provided by proton MRS combined with MRI is useful for differentiating among metastatic brain tumors, radiation necroses, and brain abscesses.


Asunto(s)
Absceso Encefálico/diagnóstico , Neoplasias Encefálicas/diagnóstico , Traumatismos por Radiación/diagnóstico , Adulto , Anciano , Anciano de 80 o más Años , Encéfalo/patología , Neoplasias Encefálicas/secundario , Diagnóstico Diferencial , Femenino , Humanos , Imagen por Resonancia Magnética , Espectroscopía de Resonancia Magnética , Masculino , Persona de Mediana Edad , Necrosis , Protones , Sensibilidad y Especificidad
7.
Kaohsiung J Med Sci ; 20(1): 1-5, 2004 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15481559

RESUMEN

Prostaglandin E2 (PGE2) plays an important role in immunosuppression and tumor growth. PGE2 inhibitors such as aspirin and indomethacin suppress experimental tumor growth. Little is known of the relationship between PGE2 synthesis in brain tumors and the dose of aspirin or indomethacin. The present study was undertaken to evaluate the effect of different doses of aspirin and indomethacin on PGE2 synthesis in C6 glioma cells. C6 glioma cells were incubated with different concentrations (2, 4, and 8 microM) of aspirin and indomethacin for 1, 2, 4, 6, 8, 12, and 24 hours. Intracellular PGE2 concentration was measured by enzyme immunoassay. Each concentration of aspirin and indomethacin effectively inhibited PGE2 synthesis. Concentrations of 2, 4, and 8 microM of aspirin significantly inhibited PGE2 production at 6, 4, and 1 hour, respectively, and the inhibition persisted for more than 24 hours (p < 0.05). Concentrations of 2 and 4 microM of indomethacin were effective at 4 and 2 hours (p < 0.05), respectively. However, inhibition was not observed beyond 12 hours (p > 0.05). Indomethacin 8 microM was effective at 1 hour and the inhibition persisted beyond 24 hours (p < 0.05). Our study demonstrates that aspirin and indomethacin inhibit PGE2 synthesis in C6 glioma cells and that low-dose aspirin is as effective as high-dose aspirin. This study may encourage future clinical use of low-dose aspirin in the prevention or treatment of brain tumors.


Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Aspirina/farmacología , Dinoprostona/biosíntesis , Indometacina/farmacología , Neoplasias Encefálicas/tratamiento farmacológico , Neoplasias Encefálicas/metabolismo , Neoplasias Encefálicas/patología , Relación Dosis-Respuesta a Droga , Glioma/tratamiento farmacológico , Glioma/metabolismo , Glioma/patología , Humanos , Técnicas para Inmunoenzimas , Factores de Tiempo , Células Tumorales Cultivadas
8.
J Spinal Disord Tech ; 18(4): 326-31, 2005 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16021013

RESUMEN

Anterior discectomy and fusion to treat cervical degenerative disc disease is the preferred procedure for many spine surgeons. The ideal device for structural reconstruction of the anterior cervical spine remains controversial. The purpose of this prospective study was to investigate the effectiveness of a non-threaded titanium cage in performing anterior spinal fusion for cervical degenerative disc disease. The clinical and radiologic data of 78 consecutive patients were reviewed. Neurologic outcome was assessed using Odom's criteria. Neck pain was graded using a 10-point visual analog scale. The cervical spinal curvature, the height of foramina, and fusion status were evaluated on preoperative and postoperative radiographs. Mean follow-up was 24.9 (range 18-35) months. An excellent or good result was found in 92% of the patients with radiculopathy, 69% of those with myelopathy, and 73% of those with myeloradiculopathy. Statistical analyses also showed improvement of cervical pain after surgery (P < 0.001) and a significant increase in foraminal height (P = 0.035). Cervical kyphosis was present in 27 (34%) patients before surgery; it was corrected to lordosis in 9. The fusion rate at 12 months and 24 months was 91% and 95%, respectively. No surgery or cage-related complication occurred in these patients. Non-threaded interbody cage fusion in this study achieved a high fusion rate and had a good neurologic outcome. These results suggest that non-threaded cage fusion is a safe and effective method for anterior cervical discectomy.


Asunto(s)
Vértebras Cervicales/cirugía , Discectomía , Fijadores Internos , Disco Intervertebral/cirugía , Enfermedades de la Columna Vertebral/cirugía , Fusión Vertebral/métodos , Titanio , Adulto , Anciano , Anciano de 80 o más Años , Vértebras Cervicales/diagnóstico por imagen , Femenino , Estudios de Seguimiento , Humanos , Disco Intervertebral/diagnóstico por imagen , Cifosis/diagnóstico por imagen , Masculino , Persona de Mediana Edad , Dolor de Cuello/fisiopatología , Dimensión del Dolor , Periodo Posoperatorio , Estudios Prospectivos , Radiografía , Enfermedades de la Columna Vertebral/diagnóstico por imagen , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA